AtriCure Acquires nContact Surgical for $149,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bde2f82a-ae2e-46db-be2f-40014b01a11b
Date
10/6/2015
Company Name
nContact Surgical
Mailing Address
1001 Aviation Pkwy. Morrisville, NC 27560 USA
Company Description
nContact is a medical device company founded in 2005 with a mission to develop devices for the endoscopic treatment of arrhythmias, including atrial fibrillation (AF).
Website
http://www.ncontactsurgical.com
Transaction Type
M&A
Transaction Amount
$149,000,000
Transaction Round
Proceeds Purposes
M&A Terms
The transaction consideration consists of an upfront payment of approximately 3.7 million shares of AtriCure common stock, valued at $24.60 per share, and approximately $8 million in cash, subject to closing adjustments. The transaction also includes up to $50 million in additional contingent consideration based on completion of enrollment of the CONVERGE IDE trial and PMA approval. Additionally, nContact shareholders are entitled to additional sales-based contingent consideration on revenue in excess of an annual growth rate of greater than 25% through 2019. All contingent consideration can be paid in either cash or AtriCure common stock, or a combination of both.